Gene therapy by mitochondrial transfer

Advanced Drug Delivery Reviews

Volumn 49, Issue 1-2, 2001, Pages 107-119

  Kagawa, Yasuo ^a,b   Inoki, Yutaka ^a   Endo, Hitoshi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Nutrition University   (Japan)

Author keywords

Cybrids; Cytoplasts; Heteroplasmy; Homoplasmy; Mitochondrial DNA; Stochastic segregation; Transmitochondrial mouse

Indexed keywords

CLONING; DISEASES; DNA; DRUG THERAPY; GENES; MUTAGENESIS;

GENETICS;

GENETIC ENGINEERING;

DNA;

CELL FUSION; CELL HYBRIDIZATION; CELL MUTANT; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DELIVERY SYSTEM; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HETEROPLASMY; HUMAN; HYBRID CELL; MICROINJECTION; MITOCHONDRION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; REVIEW;

EID: 0035797115     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00129-6     Document Type: Article

References (77)

1. Generation of mice with mitochondrial dysfunction by introducing mouse deletion mutant mtDNA into zygotes
2. Transmitochondrial mice carrying resistance to chloramphenicol on mitochondrial DNA: Developing the first mouse model of mitochondrial DNA disease
3. Viable offspring derived from fetal and adult mammalian cells
4. Mitochondrial DNA genotypes in nuclear transfer-derived cloned sheep
5. Gene therapy of mitochondrial diseases using human cytoplasts
6. Genetic and functional changes in mitochondria associated with aging
7. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease
8. Nuclear but not mitochondrial genome involvement in human age-related mitochondrial dysfunction. Functional integrity of mitochondrial DNA from aged subjects
9. Isolation of mitochondrial DNA-less mouse cell lines and their application for trapping mouse synaptosomal mitochondrial DNA with deletion mutations
10. Introduction of mitochondria into mouse fertilized egg
11. DQAsomes: A novel potential drug and gene delivery system made from Dequalinium
12. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes
13. Sequence and organization of the human mitochondrial genome
14. Mitochondrial diseases in man and mouse
15. Mitochondrial medicine - Recent advances
16. Similarity of human mitochondrial transcription factor 1 to high mobility group proteins
17. Smaller isoform of human mitochondrial transcription factor 1: Its wide distribution and production by alternative splicing
18. Upstream region of a genomic gene for human mitochondrial transcription factor 1
19. The role of mitochondria in the pathogenesis of neurodegenerative diseases
20. Mitochondrial redox signaling during apoptosis
21. Leu (UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes)
22. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies
23. tRNA Lys mutation
24. Leber's hereditary optic neuropathy. New genetic considerations
25. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy
26. Mitochondrial tRNA Ile mutation in fatal cardiomyopathy
27. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayer Syndrome
28. Multiple deletions of mitochondrial DNA in patients with familial mitochondrial myopathy
29. Maternally inherited diabetes and deafness: Prevalence in a hospital diabetic populations
30. Mitochondrial DNA mutations in human degenerative diseases and aging
31. Marked decrease of mitochondrial DNA with multiple deletions in a patient with familial mitochondrial myopathy
32. Alteration of mitochondrial DNA in human oncocytomas
33. Regulation of energy metabolism in human cells in aging and diabetes: FoF1, mtDNA, UCP, and ROS
34. Content of mutant mitochondrial DNA and organ-dysfunction in a patient with a MELAS-subgroup of mitochondrial encephalomyopathies
35. Widespread tissue distribution of multiple mitochondrial DNA deletions in familial mitochondrial myopathy
36. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation
37. Cells depleted of mitochondrial DNA (rhoO) yield insight into physiological mechanisms
38. Functional and morphological abnormalities of mitochondria in human cells containing mitochondrial DNA with pathogenic point mutations in tRNA genes
39. Nuclear-recessive mutations of factors involved in mitochondrial translation are responsible for age-related respiration deficiency of human skin fibroblasts
40. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction
41. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
42. Somatic cell genetical approaches to mitochondrial diseases
43. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia
44. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
45. Particle-mediated gene transfer of murine interleukin-12 cDNA suppress the growth of Lewis lung carcinoma
46. Organelle transformation: Shoot first, ask question later
47. Towards gene therapy of mitochondrial disorders
48. Mitochondrially-imported cytoplasmic tRNALys(CUU) of Saccharomyces cerivisiae: In vivo and in vitro targeting systems
49. Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids
50. Introduction of plasmid DNA into isolated mitochondria by electroporation. A novel approach towards gene correction for mitochondrial disorders
51. Rat liver GTP-binding proteins mediate changes in mitochondrial membrane potential and organelle fusion
52. Genes of human ATP synthase: Their roles in physiology and aging
53. MyoD is indispensable for muscle-specific alternative splicing in mouse mitochondrial ATP synthase gamma-subunit pre-mRNA
54. Differential regulation of exonic regulatory elements for muscle-specific alternative splicing during myogenesis and cardiogenesis
55. Microinjection of mitochondria into zygotes creates a model for studying the inheritance of mitochondrial DNA during preimplantation development
56. Elimination of paternal mitochondrial DNA in intraspecific crosses during early mouse embryogenesis
57. Transfection of mitochondria: Strategy towards a gene therapy of mitochondrial DNA diseases
58. Mitochondrial genotype segregation and effects during mammalian development: Applications to biotechnology
59. Strategies for making more organs available for transplantation
60. Chronic rejection of renal transplants: New clinical insights
61. Telomeres, telomerase, and myc. An update
62. Telomere length predicts replicative capacity of human fibroblasts
63. DNA damage and repair in telomerase: Relation to aging
64. Analysis of telomere lengths in cloned sheep
65. Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases
66. Superoxide radical and superoxide dismutases
67. Age-associated changes of mitochondrial translation and respiratory function in mouse brain
68. Mitochondrial DNA remains intact during Drosophila aging, but the levels of mitochondrial transcripts are significantly reduced
69. Mitochondrial decay in aging
70. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family
71. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness
72. A common mitochondrial DNA variant is associated with insulin resistance in adult life
73. Mitochondrial genotype associated with longevity
74. Transcription of the MRP RNA gene in frog stage I oocytes requires a novel cis-element
75. Regulation of mitochondrial ATP synthesis in mammalian cells by transcriptional control
76. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease
77. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines